Maynard Um
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Sangamo BioSciences (SGMO)
-
-
-
-
-
-
-
Sangamo Therapeutics (SGMO) Announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry Disease
-
-
-
-
-
-
-
Sangamo BioSciences (SGMO) PT Lowered to $5 at Truist Securities
-
-
-
-
-
-
-
Sangamo Therapeutics (SGMO) Tops Q3 EPS by 6c, provides guidance
-
-
-
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

